Relmada Therapeutics, Inc. (RLMD)
5.91
-0.24
(-3.90%)
USD |
NASDAQ |
Mar 13, 16:00
5.90
-0.01
(-0.17%)
After-Hours: 20:00
Relmada Therapeutics Market Cap : 433.40M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.512B |
| Invivyd, Inc. | 405.63M |
| Arcellx, Inc. | 6.690B |
| AN2 Therapeutics, Inc. | 135.37M |
| ACADIA Pharmaceuticals, Inc. | 3.514B |
Market Cap Related Metrics
| Price to Book Value | 45.79 |
| Price | 5.91 |
| Earnings Yield | -30.41% |